BlueCrest Capital Management’s Athenahealth, Inc. ATHN Stock Holding History

BlueCrest Capital Management’s Portfolio ATHN Stock Details ATHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-7,121	Closed	-$947K	–	1714
2017 Q4	$947K	Buy	+7,121	New	+$910K	0.03%	397
2017 Q3	–	Sell	-12,012	Closed	-$1.69M	–	1211
2017 Q2	$1.69M	Buy	+12,012	New	+$1.5M	0.07%	364
2016 Q4	–	Sell	-4,000	Closed	-$504K	–	970
2016 Q3	$504K	Buy	4,000 +1,064	+36%	+$135K	0.02%	531
2016 Q2	$405K	Sell	2,936 -2,964	-50%	-$392K	0.02%	596
2016 Q1	$819K	Buy	+5,900	New	+$809K	0.05%	417

Other funds holding ATHN

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

BlueCrest Capital Management's ATHN Position: Q1 2018 in Review

BlueCrest Capital Management sold out of Athenahealth, Inc. (ATHN) in Q1 2018, closing a stake of 7,121 shares — an estimated $947K sold.

BlueCrest Capital Management first reported a position in ATHN in Q1 2016 and held it in 5 quarters. The position peaked at $1.69M in Q2 2017. 259 funds tracked by Wall St. Rank hold ATHN as of Q1 2018.

BlueCrest Capital Management reported no remaining Athenahealth, Inc. position as of Q1 2018 after selling out during the quarter.
BlueCrest Capital Management sold 7,121 Athenahealth, Inc. shares in Q1 2018, an estimated $947K.
BlueCrest Capital Management first reported a position in Athenahealth, Inc. in Q1 2016 and held it in 5 quarters.
BlueCrest Capital Management's Athenahealth, Inc. position peaked at $1.69M in Q2 2017.
259 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2018.

Based on BlueCrest Capital Management's 13F filing for Q1 2018, filed 15 May 2018.